Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2017-11-29
DOI
10.1080/21691401.2017.1408124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipid drug conjugate nanoparticle as a potential nanocarrier for the oral delivery of pemetrexed diacid: Formulation design, characterization, ex vivo , and in vivo assessment
- (2017) Kriti Soni et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lipid Based nanoformulation of lycopene improves oral delivery: formulation optimization, ex vivo assessment and its efficacy against breast cancer
- (2017) Archu Singh et al. JOURNAL OF MICROENCAPSULATION
- Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL–PEG–PCL copolymeric-based micelles
- (2017) Hamidreza Kheiri Manjili et al. Artificial Cells Nanomedicine and Biotechnology
- Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics
- (2017) Md. Habban Akhter et al. Artificial Cells Nanomedicine and Biotechnology
- Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma
- (2016) Afreen Qidwai et al. DRUG DELIVERY
- Carvedilol nano lipid carriers: formulation, characterization andin-vivoevaluation
- (2016) Akansha Mishra et al. DRUG DELIVERY
- Nanostructured lipid–carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux
- (2016) Guixia Ling et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers
- (2016) Md. Rizwanullah et al. JOURNAL OF DRUG TARGETING
- Application of Box–Behnken design for preparation of glibenclamide loaded lipid based nanoparticles: Optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study
- (2016) Mohammed Aslam et al. JOURNAL OF MOLECULAR LIQUIDS
- Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
- (2016) Anam Khan et al. MOLECULAR PHARMACEUTICS
- Nanostructured lipid carriers: Promising drug delivery systems for future clinics
- (2016) Ana Beloqui et al. Nanomedicine-Nanotechnology Biology and Medicine
- Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach
- (2016) Seyedeh Marziyeh Mahdavi Moghddam et al. Artificial Cells Nanomedicine and Biotechnology
- Enhancing activity of artesunate against breast cancer cells via induced-apoptosis pathway by loading into lipid carriers
- (2016) Tuan Hiep Tran et al. Artificial Cells Nanomedicine and Biotechnology
- Nanostructured Lipid Carriers: A Novel Platform for Chemotherapeutics
- (2016) Md. Rizwanullah et al. Current Drug Delivery
- Effect of oil and co-surfactant on the formation of Solutol HS 15 based colloidal drug carrier by Box–Behnken statistical design
- (2014) Javed Ahmad et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail
- (2014) Sohrab Alam et al. DRUG DELIVERY
- Lipid based nanocarrier system for the potential oral delivery of decitabine: Formulation design, characterization, ex vivo, and in vivo assessment
- (2014) Yub Raj Neupane et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tamoxifen nanostructured lipid carriers: Enhanced in vivo antitumor efficacy with reduced adverse drug effects
- (2014) Harshad K. Shete et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Quality by Design Approach for Self Nanoemulsifying System of Paclitaxel
- (2014) Javed Ahmad et al. Science of Advanced Materials
- Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: Application of factorial design approach
- (2014) Ganesh B. Patil et al. Artificial Cells Nanomedicine and Biotechnology
- Nanostructured lipid carriers and their current application in targeted drug delivery
- (2014) Piyush Jaiswal et al. Artificial Cells Nanomedicine and Biotechnology
- Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, andγScintigraphy Imaging
- (2014) Javed Ahmad et al. Biomed Research International
- Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier
- (2012) Ana Beloqui et al. JOURNAL OF CONTROLLED RELEASE
- Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide
- (2011) Tiecheng Zhang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Sulforaphane Inhibits Constitutive and Interleukin-6-Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells
- (2010) E. R. Hahm et al. Cancer Prevention Research
- Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
- (2010) Vanessa Rausch et al. CANCER RESEARCH
- Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers
- (2010) S.W. Tan et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Non-destructive methods of characterization of risperidone solid lipid nanoparticles
- (2010) Ziyaur Rahman et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Sulforaphane: from chemoprevention to pancreatic cancer treatment?
- (2009) J. W Lampe GUT
- Multi-targeted prevention of cancer by sulforaphane
- (2008) John D. Clarke et al. CANCER LETTERS
- Sulforaphane targets pancreatic tumour-initiating cells by NF- B-induced antiapoptotic signalling
- (2008) G Kallifatidis et al. GUT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started